Author [ref.] year
|
Follow-up months
|
Definition of OA for inclusion
|
Age, years
|
Women, %
|
No. of patients
|
Quality score
|
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
---|
Amin [10] 2009
|
30
|
ACR criteria
|
69
|
42
|
265
|
13
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
Tanamas [35] 2010
|
24
|
K/L
|
63.2 ± 10.3
|
51
|
109
|
13
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
Cicuttini [14] 2004
|
24
|
K/L
|
63.1 ± 10.3
|
58
|
113
|
12
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
Hill [19] 2007
|
30
|
ACR criteria
|
66.7 ± 9.2
|
41
|
233
|
12
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
Holla [21] 2014
|
60
|
ACR criteria
|
56.0 ± 5.1
|
81.3
|
697
|
12
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
Tanamas [36] 2010
|
24
|
ACR criteria
|
63.2 ± 10.3
|
70
|
109
|
12
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
Berry [12] 2010
|
24
|
ACR criteria
|
63.7 ± 10.3
|
58
|
117
|
11
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
Henriksen [18] 2013
|
12
|
K/L
|
63
|
82
|
157
|
11
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
Yang [38] 2015
|
36
|
K/L
|
43 % >65
|
58
|
1,625
|
11
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
Alschuler [9] 2013
|
12
|
K/L
|
65.3 ± 9.0
|
59
|
797
|
10
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
Amin [11] 2008
|
30
|
ACR criteria
|
67 ± 9
|
43
|
265
|
10
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
Collins [15] 2014
|
72
|
K/L
|
62 ± 9
|
59
|
1,753
|
10
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
Holla [20] 2010
|
24
|
ACR criteria
|
56.0 ± 5.1
|
80
|
832
|
10
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
Lapane [22] 2015
|
48
|
K/L
|
70
|
58
|
1,846
|
10
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
Larsson [23] 2012
|
90
|
OARSI
|
50 (32–73)
|
18
|
74
|
10
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
Laslett [24] 2014
|
60
|
K/L
|
61
|
100
|
323
|
10
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
Muraki [25] 2012
|
40
|
K/L
|
68.7 ± 11.3
|
75
|
1,313
|
10
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
Podsiadlo [28] 2014
|
72
|
ACR criteria
|
63.9
|
57
|
114
|
10
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
Riddle [30] 2012
|
48
|
OARSI
|
62
|
58
|
4,670
|
10
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
Roemer [32] 2014
|
60
|
K/L
|
64.2 ± 8.4
|
58
|
398
|
10
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
Bruyere [13] 2005
|
45.6
|
ACR criteria
|
64.7 ± 7.0
|
70
|
139
|
9
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
0
|
Conaghan [16] 2010
|
36
|
K/L
|
67 ± 10
|
73
|
531
|
9
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
Sharma [34] 2003
|
36
|
K/L
|
68.6 ± 10.8
|
73
|
236
|
9
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
Eckstein [17] 2013
|
48
|
K/L
|
58
|
64
|
97
|
8
|
1
|
0
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
Oak [26] 2013
|
48
|
K/L
|
61.2 ± 9.1
|
53
|
942
|
8
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
Riddle [29] 2009
|
24
|
K/L
|
61.6 ± 9.3
|
60
|
778
|
8
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
Scher [33] 2008
|
36
|
K/L
|
51
|
63
|
73
|
8
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
van Dijk [37] 2011
|
36
|
ACR criteria
|
65.9 ± 8.3
|
74
|
174
|
8
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
Pisters [27] 2012
|
60
|
ACR criteria
|
66.1 ± 8.5
|
74
|
216
|
7
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
Riddle [31] 2013
|
33
|
K/L
|
62.7 ± 8.6
|
63
|
1,410
|
7
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
- A–M represent criteria scores (see Table 1). ACR American College of Rheumatology, K/L Kellgren and Lawrence score, OA, osteoarthritis, OARSI Osteoarthritis Research Society International Atla